1. Home
  2. NSPR vs CXH Comparison

NSPR vs CXH Comparison

Compare NSPR & CXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • CXH
  • Stock Information
  • Founded
  • NSPR 2005
  • CXH 1989
  • Country
  • NSPR United States
  • CXH United States
  • Employees
  • NSPR N/A
  • CXH N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • CXH Investment Managers
  • Sector
  • NSPR Health Care
  • CXH Finance
  • Exchange
  • NSPR Nasdaq
  • CXH Nasdaq
  • Market Cap
  • NSPR 74.8M
  • CXH 62.5M
  • IPO Year
  • NSPR N/A
  • CXH N/A
  • Fundamental
  • Price
  • NSPR $2.69
  • CXH $7.46
  • Analyst Decision
  • NSPR Strong Buy
  • CXH
  • Analyst Count
  • NSPR 2
  • CXH 0
  • Target Price
  • NSPR $4.50
  • CXH N/A
  • AVG Volume (30 Days)
  • NSPR 109.3K
  • CXH 25.9K
  • Earning Date
  • NSPR 08-05-2025
  • CXH 01-01-0001
  • Dividend Yield
  • NSPR N/A
  • CXH 3.56%
  • EPS Growth
  • NSPR N/A
  • CXH N/A
  • EPS
  • NSPR N/A
  • CXH 0.23
  • Revenue
  • NSPR $7,027,000.00
  • CXH N/A
  • Revenue This Year
  • NSPR $4.85
  • CXH N/A
  • Revenue Next Year
  • NSPR $113.47
  • CXH N/A
  • P/E Ratio
  • NSPR N/A
  • CXH $33.35
  • Revenue Growth
  • NSPR 8.49
  • CXH N/A
  • 52 Week Low
  • NSPR $1.99
  • CXH $6.41
  • 52 Week High
  • NSPR $3.80
  • CXH $7.74
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 62.76
  • CXH 48.53
  • Support Level
  • NSPR $2.37
  • CXH $7.34
  • Resistance Level
  • NSPR $2.92
  • CXH $7.40
  • Average True Range (ATR)
  • NSPR 0.16
  • CXH 0.05
  • MACD
  • NSPR 0.03
  • CXH 0.00
  • Stochastic Oscillator
  • NSPR 66.18
  • CXH 66.67

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About CXH MFS Investment Grade Municipal Trust

Mfs Investment Grade Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowing for investment purposes, in tax-exempt bonds and tax-exempt notes.

Share on Social Networks: